Business
Why the MedAdvisor (ASX:MDR) share price is pushing higher today
The MedAdvisor Ltd (ASX: MDR) share price has been a positive performer on Monday morning.
At the time of writing, the medication management platform provider’s shares are up 2.5% to 40 cents.
Why is the MedAdvisor share price pushing higher?
Investors have been buying the company’s shares this morning after the release of a trading update.
According to the release, MedAdvisor’s US subsidiary, Adheris, has been performing better than it anticipated since being acquired on 17 November.
In light of this, the company is expecting Adheris’ revenue to be higher than the guidance it previously provided.
For the period 1 July to the end of November, Adheris achieved revenue of US$14 million. This compares to half year revenue…
-
Business6 hours agoSoaring one day, plunging the next. Why is the ASX 200 on a rollercoaster?
-
Business13 hours agoHow I’d build a $100,000 ASX portfolio from scratch
-
Noosa News8 hours agoBrisbane man Benjamin Holt speaks out about teen who allegedly organised Airbnb party that led to his house being trashed
-
Business9 hours agoWhy this ASX 200 share could be a top defensive buy